• HITGEN AND MSD ENTER Research Collaboration

    Chengdu, China,22nd March, 2017, HitGen Ltd announced that the company has entered into a collaboration with MSD, known as Merck in the United States and Canada, to discover novel chemical leads for multiple therapeutic targets of interest to MSD…

    HITGEN AND MSD ENTER Research Collaboration
     
  • HITGEN AND CANCER RESEARCH UK’S MANCHESTER INSTITUTE ENTER LICENCE AGREEMENT IN LUNG CANCER

    Cancer Research UK, Cancer Research Technology (CRT), the charity’s commercial arm, and HitGen Ltd, a privately held biotech company focused on early drug discovery, announced today that they have entered into a licence agreement to develop a novel class of drugs against lung cancer…

    HITGEN AND CANCER RESEARCH UK’S MANCHESTER INSTITUTE  ENTER LICENCE AGREEMENT IN LUNG CANCER
     
  • New Drug Discovery: Find Needles in Very Large Haystacks

    Aug 23th, as the first speaker of 5th IAPC Meeting, Dr. Jin Li introduced the technical principle of DNA Encoded Library (DELs) synthesis and screening and its potential impact on the early new drug discovery, which attracted several attendees’ interest. Subsequently scientists from all over the world shared their current technology in different research areas. Everyone spoke out freely and gave full play to his strong point during the conference.

    New Drug Discovery: Find Needles in Very Large Haystacks
     
  • Greeting from CEO

    At HitGen, we will do our utmost to understand your business and scientific needs, and to build long-term partnership through high quality and efficient delivery and effective interactions. I look forward to working with you and your organization.

    Greeting from CEO
     
  • Lead Generation by DNA Encoded Chemical Libraries (DELs)

    Using our powerful platform, we provide our partners services which focus on quality, speed and efficiency, delivering value for money. Our products and services include Targets to Hit/Leads, Hits/Leads Expansion, as well as progressing selected programmes to pre-clinical and early clinical stages.

    Lead Generation by DNA Encoded Chemical Libraries (DELs)
     
  • High-throughput Sequencing

    HitGen has established an Illumina HiSeq 2500 based next-generation DNA sequencing platform. Our DNA sequencing laboratory is built under strict accordance with requirements of ISO17025. HitGen high throughput platform now offers DNA sample preparation and sequencing service including exome capture sequencing, transcriptome sequencing, metagenome sequencing and so on.

    High-throughput Sequencing
     
HitGen: Advancing Innovative Drug Discoveries

Target to Hits/Leads

Custom compound libraries

Collaborative Drug Discovery Programmes with Partners

Research Support


HitGen is a life science company with a focus on hit identification and lead generation. Our core capabilities include medicinal chemistry, computational chemistry, high speed synthesis, cell and molecular biology, in vitro screening and selection. Our core assets are large, diverse and high quality encoded chemical libraries.

We provide products and services to our partners which enable them to progress targets to hits/leads, and eventually to pre-clinical and early clinical stages.


Google+

Link:
hitgenbiomed.com Medicinal Chemistry